Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
FIGS
Upturn stock ratingUpturn stock rating

Figs Inc (FIGS)

Upturn stock ratingUpturn stock rating
$4.51
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

04/01/2025: FIGS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -74.75%
Avg. Invested days 21
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 04/01/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 763.84M USD
Price to earnings Ratio 229.5
1Y Target Price 5.26
Price to earnings Ratio 229.5
1Y Target Price 5.26
Volume (30-day avg) 2528063
Beta 1.26
52 Weeks Range 4.18 - 7.05
Updated Date 04/1/2025
52 Weeks Range 4.18 - 7.05
Updated Date 04/1/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.02

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 0.49%
Operating Margin (TTM) 5.86%

Management Effectiveness

Return on Assets (TTM) 0.29%
Return on Equity (TTM) 0.72%

Valuation

Trailing PE 229.5
Forward PE 114.94
Enterprise Value 553879777
Price to Sales(TTM) 1.37
Enterprise Value 553879777
Price to Sales(TTM) 1.37
Enterprise Value to Revenue 1
Enterprise Value to EBITDA 61.82
Shares Outstanding 154236992
Shares Floating 148782379
Shares Outstanding 154236992
Shares Floating 148782379
Percent Insiders 5.42
Percent Institutions 97.12

Analyst Ratings

Rating 3.09
Target Price 5.69
Buy 1
Strong Buy 1
Buy 1
Strong Buy 1
Hold 7
Sell 2
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Figs Inc

stock logo

Company Overview

History and Background

Figs Inc. was founded in 2013 by Heather Hasson and Trina Spear. They identified a need for more stylish and functional medical apparel. Figs went public in May 2021. They disrupted the traditional medical apparel market by focusing on direct-to-consumer sales, innovative fabrics, and community engagement.

Core Business Areas

  • Apparel: Figs primarily sells medical apparel, including scrubs, lab coats, and other workwear designed for healthcare professionals. This is their core revenue driver.
  • Lifestyle: Figs also offers lifestyle apparel, such as compression socks, outerwear, and accessories, expanding their brand beyond the medical field.
  • Team Sales: Figs offers team sales for medical organizations, providing bulk orders with customized branding and features. This can often be a lucrative area for repeat business for the company.

Leadership and Structure

Figs Inc. is led by CEO Trina Spear. The organizational structure includes departments for product development, marketing, sales, operations, finance, and technology. They have a board of directors overseeing the company's strategic direction.

Top Products and Market Share

Key Offerings

  • Core Scrubs: Figs' core scrubs are their most popular product, known for their comfortable, durable, and stylish design. While precise market share data is difficult to obtain, Figs is estimated to be one of the leading scrub brands in the US. Competitors include Careismatic Brands (Cherokee, Dickies), Med Couture, and Jaanuu. Revenue attributed to core scrubs makes up the majority of revenue but figures are unavailable
  • Lab Coats: Figs lab coats offer healthcare professionals an improved fit, with stain and anti-microbial features. They also incorporate new technology to address medical safety. Competitors include Landau and Medline. Revenue attributed to lab coats is not publicly available but is likely a smaller percentage than their scrub revenue.
  • Lifestyle Apparel: Figs has expanded into lifestyle apparel, including compression socks, outerwear, and accessories. No market share available and competitors are mainstream brands like Nike and Lululemon. The revenue attributed to lifestyle apparel is likely smaller than their scrub revenue.

Market Dynamics

Industry Overview

The medical apparel industry is a growing market driven by the increasing demand for healthcare services and the need for functional and comfortable workwear. It is becoming increasingly fragmented with the rise of direct-to-consumer brands.

Positioning

Figs is positioned as a premium direct-to-consumer brand in the medical apparel market. Their competitive advantages include their innovative fabrics, stylish designs, strong brand image, and direct-to-consumer business model.

Total Addressable Market (TAM)

The global medical apparel market is estimated to be around $60 billion. Figs is positioned to capture a larger share of this market through continued product innovation, market expansion, and brand building.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition
  • Innovative product design
  • Direct-to-consumer business model
  • High customer loyalty
  • Data-driven decision making

Weaknesses

  • Relatively high price point
  • Limited physical retail presence
  • Dependence on online sales channels
  • Supply chain vulnerabilities

Opportunities

  • Expansion into new product categories
  • International market expansion
  • Strategic partnerships with healthcare organizations
  • Increased focus on team sales
  • Development of new technologies for medical apparel

Threats

  • Increased competition from established players and new entrants
  • Changes in consumer preferences
  • Economic downturn
  • Supply chain disruptions
  • Fluctuations in raw material costs

Competitors and Market Share

Key Competitors

  • Cintas Corporation (CTAS)
  • Careismatic Brands Inc. (Private)
  • Jaanuu (Private)

Competitive Landscape

Figs benefits from being a D2C brand. Its innovation puts it ahead of its competitors; however, because it is more expensive, it may be more affected by any economic downturn than Cintas (CTAS) which has more affordable apparel.

Major Acquisitions

Growth Trajectory and Initiatives

Historical Growth: Figs has experienced significant revenue growth in recent years, driven by increased brand awareness, product innovation, and expansion of its customer base.

Future Projections: Analyst estimates suggest continued revenue growth for Figs, fueled by its strong brand, innovative products, and expansion into new markets and product categories.

Recent Initiatives: Recent strategic initiatives undertaken by Figs include expanding its lifestyle apparel offerings, focusing on team sales, and investing in its supply chain.

Summary

Figs is a growing brand in medical apparel known for innovative fabric, style and a D2C approach. The brand has a strong following from its customers. As the brand expands into new categories it can capitalize on a wider audience of consumers. An economic downturn might affect the brand's higher pricing. More competition from established players may be a future challenge.

Similar Companies

  • LULU
  • CTAS
  • VNT
  • WWD

Sources and Disclaimers

Data Sources:

  • Company SEC Filings
  • Market Research Reports
  • Analyst Estimates

Disclaimers:

The data provided is for informational purposes only and should not be considered investment advice. Market share data is estimated and may not be precise. Financial data is based on publicly available information and may be subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Figs Inc

Exchange NYSE
Headquaters Santa Monica, CA, United States
IPO Launch date 2021-05-27
Co-Founder, CEO & Director Ms. Catherine Eva Spear
Sector Consumer Cyclical
Industry Apparel Manufacturing
Full time employees 303
Full time employees 303

FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. The company designs and sells scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings and tops, super-soft pima cotton tops, vests, fleeces, and jackets; and necessities comprising scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail stores. FIGS, Inc. was incorporated in 2013 and is headquartered in Santa Monica, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​